Cytochrome P450 2C19 (CYP2C19) genotype appears to affect the efficacy of omeprazole

By  

Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Effect of the Cytochrome P450 2C19 Inhibitor Omeprazole on the Pharmacokinetics and Safety Profile of Bortezomib in Patients with Advanced Solid Tumours, Non-Hodgkin's Lymphoma or Multiple Myeloma

By Quinn David I.  

Clinical Pharmacokinetics, Vol. 48, Iss. 3, 2009-01 ,pp. : 199-209

Adis International

Access to resources Recommend Favorite

Fatal intoxication cases: cytochrome P ₄₅₀ 2D6 and 2C19 genotype distributions

By Zackrisson A.   Holmgren P.   Gladh A.   Ahlner J.   Lindblom B.  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 547-552

Springer Publishing Company

Access to resources Recommend Favorite

Exploring the Relationship Between Expression of Cytochrome P450 Enzymes and Gefitinib Pharmacokinetics

By Swaisland Helen C.  

Clinical Pharmacokinetics, Vol. 45, Iss. 6, 2006-01 ,pp. : 633-644

Adis International

Access to resources Recommend Favorite

Influence of Cytochrome P450 (CYP) 3A5 Polymorphisms on the Pharmacokinetics of Lansoprazole Enantiomers in CYP2C19 Extensive Metaboliser Renal Transplant Recipients

By Miura Masatomo  

Clinical Drug Investigation, Vol. 27, Iss. 4, 2007-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite